Neuroprotective and neuroregenerative properties of metallothioneins

IUBMB Life

Volumn 64, Issue 2, 2012, Pages 126-135

  Santos, Cecília R A ^a   Martinho, Ana ^a   Quintela, Telma ^a   Gonçalves, Isabel ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Alzheimer disease; brain; metallothionein 1; metallothionein 2; metallothionein 3; neuroprotection; neuroregeneration; oxidative stress; zinc binding

Indexed keywords

METALLOTHIONEIN; METALLOTHIONEIN I; METALLOTHIONEIN II; ZINC;

ANTIOXIDANT ACTIVITY; CENTRAL NERVOUS SYSTEM; DETOXIFICATION; GENE STRUCTURE; HUMAN; METAL BINDING; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW;

ANIMALS; ANTIOXIDANTS; BRAIN; COPPER; CYTOPROTECTION; HUMANS; METALLOTHIONEIN; MUTATION; NERVE REGENERATION; NEURONS; PROTEIN BINDING; UBIQUITIN-PROTEIN LIGASES;

EID: 84855863743     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.585     Document Type: Review

References (78)

1. West, A. K., Stallings, R., Hildebrand, C. E., Chiu, R., Karin, M., et al. (1990) Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8, 513-518.
2. Vasak, M., (2005) Advances in metallothionein structure and functions. J. Trace Elem. Med. Biol. 19, 13-17. (Pubitemid 41253912)
3. Goncalves, I., Quintela, T., Baltazar, G., Almeida, M. R., Saraiva, M. J., et al. (2008) Transthyretin interacts with metallothionein 2. Biochemistry 47, 2244-2251. (Pubitemid 351304532)
4. Hozumi, I., Suzuki, J. S., Kanazawa, H., Hara, A., Saio, M., et al. (2008) Metallothionein-3 is expressed in the brain and various peripheral organs of the rat. Neurosci. Lett. 438, 54-58.
5. Irie, Y., Mori, F., Keung, W. M., Mizushima, Y., and, Wakabayashi, K., (2004) Expression of neuronal growth inhibitory factor (metallothionein-III) in the salivary gland. Physiol. Res. 53, 719-723. (Pubitemid 40065702)
6. Ding, Z. C., Ni, F. Y., and, Huang, Z. X., (2010) Neuronal growth-inhibitory factor (metallothionein-3): structure-function relationships. FEBS J. 277, 2912-2920.
7. Faller, P., (2010) Neuronal growth-inhibitory factor (metallothionein-3): reactivity and structure of metal-thiolate clusters. FEBS J. 277, 2921-2930.
8. Maret, W., (2009) Molecular aspects of human cellular zinc homeostasis: redox control of zinc potentials and zinc signals. Biometals 22, 149-157.
9. Lee, S. J., and, Koh, J. Y., (2010) Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Molecular brain 3, 30.
10. Lindeque, J. Z., Levanets, O., Louw, R., and, van der Westhuizen, F. H., (2010) The involvement of metallothioneins in mitochondrial function and disease. Curr. Protein Pept. Sci. 11, 292-309.
11. Kameo, S., Nakai, K., Kurokawa, N., Kanehisa, T., Naganuma, A., et al. (2005) Metal components analysis of metallothionein-III in the brain sections of metallothionein-I and metallothionein-II null mice exposed to mercury vapor with HPLC/ICP-MS. Anal. Bioanal. Chem. 381, 1514-1519. (Pubitemid 40609384)
12. Michalska, A. E., and, Choo, K. H., (1993) Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. USA 90, 8088-8092. (Pubitemid 23260860)
13. Chung, R. S., Adlard, P. A., Dittmann, J., Vickers, J. C., Chuah, M. I., et al. (2004) Neuron-glia communication: metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury. J. Neurochem. 88, 454-461. (Pubitemid 38084561)
14. Penkowa, M., (2006) Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J. 273, 1857-1870.
15. Martinho, A., Goncalves, I., Cardoso, I., Almeida, M. R., Quintela, T., et al. (2010) Human metallothioneins 2 and 3 differentially affect amyloid-beta binding by transthyretin. FEBS J. 277, 3427-3436.
16. Tsuji, S., Kobayashi, H., Uchida, Y., Ihara, Y., and, Miyatake, T., (1992) Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J. 11, 4843-4850. (Pubitemid 23023427)
17. Amoureux, M. C., Wurch, T., and, Pauwels, P. J., (1995) Modulation of metallothionein-III mRNA content and growth rate of rat C6-glial cells by transfection with human 5-HT1D receptor genes. Biochem. Biophys. Res. Commun. 214, 639-645.
18. Yamada, M., Hayashi, S., Hozumi, I., Inuzuka, T., Tsuji, S., et al. (1996) Subcellular localization of growth inhibitory factor in rat brain: light and electron microscopic immunohistochemical studies. Brain Res. 735, 257-264. (Pubitemid 26345937)
19. Penkowa, M., Nielsen, H., Hidalgo, J., Bernth, N., and, Moos, T., (1999) Distribution of metallothionein I + II and vesicular zinc in the developing central nervous system: correlative study in the rat. J. Comp. Neurol. 412, 303-318. (Pubitemid 29395367)
20. Carrasco, J., Giralt, M., Molinero, A., Penkowa, M., Moos, T., et al. (1999) Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains. J. Neurotrauma 16, 1115-1129.
21. Erickson, J. C., Masters, B. A., Kelly, E. J., Brinster, R. L., and, Palmiter, R. D., (1995) Expression of human metallothionein-III in transgenic mice. Neurochem. Int. 27, 35-41.
22. Penkowa, M., Carrasco, J., Giralt, M., Moos, T., and, Hidalgo, J., (1999) CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. J. Neurosci. 19, 2535-2545. (Pubitemid 29162402)
23. Carrasco, J., Penkowa, M., Hadberg, H., Molinero, A., and, Hidalgo, J., (2000) Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice. Eur. J. Neurosci. 12, 2311-2322. (Pubitemid 30497029)
24. Trendelenburg, G., Prass, K., Priller, J., Kapinya, K., Polley, A., et al. (2002) Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22, 5879-5888. (Pubitemid 35387632)
25. Wakida, K., Shimazawa, M., Hozumi, I., Satoh, M., Nagase, H., et al. (2007) Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Neuroscience 148, 105-114. (Pubitemid 47211609)
26. Penkowa, M., Camats, J., Giralt, M., Molinero, A., Hernandez, J., et al. (2003) Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression. Glia 42, 287-306. (Pubitemid 36538341)
27. van Lookeren Campagne, M., Thibodeaux, H., van Bruggen, N., Cairns, B., Gerlai, R., et al. (1999) Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 96, 12870-12875. (Pubitemid 29513595)
28. Erickson, J. C., Hollopeter, G., Thomas, S. A., Froelick, G. J., and, Palmiter, R. D., (1997) Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J. Neurosci. 17, 1271-1281. (Pubitemid 27073729)
29. Koumura, A., Hamanaka, J., Shimazawa, M., Honda, A., Tsuruma, K., et al. (2009) Metallothionein-III knockout mice aggravates the neuronal damage after transient focal cerebral ischemia. Brain Res. 1292, 148-154.
30. Carrasco, J., Penkowa, M., Giralt, M., Camats, J., Molinero, A., et al. (2003) Role of metallothionein-III following central nervous system damage. Neurobiol. Dis. 13, 22-36. (Pubitemid 36561595)
31. Giralt, M., Penkowa, M., Lago, N., Molinero, A., and, Hidalgo, J., (2002) Metallothionein-1+2 protect the CNS after a focal brain injury. Exp. Neurol. 173, 114-128. (Pubitemid 34081731)
32. Chung, R. S., Vickers, J. C., Chuah, M. I., and, West, A. K., (2003) Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury. J. Neurosci. 23, 3336-3342. (Pubitemid 36531975)
33. Penkowa, M., Tio, L., Giralt, M., Quintana, A., Molinero, A., et al. (2006) Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury. J. Neurosci. Res. 83, 974-984.
34. Manso, Y., Serra, M., Comes, G., Giralt, M., Carrasco, J., et al. (2010) The comparison of mouse full metallothionein-1 versus alpha and beta domains and metallothionein-1-to-3 mutation following traumatic brain injury reveals different biological motifs. J. Neurosci. Res. 88, 1708-1718.
35. Miyazaki, I., Asanuma, M., Kikkawa, Y., Takeshima, M., Murakami, S., et al. (2011) Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia 59, 435-451.
36. Yu, X., Guo, J., Fang, H., and, Peng, S., (2011) Basal metallothionein-I/II protects against NMDA-mediated oxidative injury in cortical neuron/astrocyte cultures. Toxicology 282, 16-22.
37. Ambjorn, M., Asmussen, J. W., Lindstam, M., Gotfryd, K., Jacobsen, C., et al. (2008) Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J.Neurochem. 104, 21-37. (Pubitemid 350265072)
38. Asmussen, J. W., Ambjorn, M., Bock, E., and, Berezin, V., (2009) Peptides modeled after the alpha-domain of metallothionein induce neurite outgrowth and promote survival of cerebellar granule neurons. Eur. J. Cell Biol. 88, 433-443.
39. Hozumi, I., Uchida, Y., Watabe, K., Sakamoto, T., and, Inuzuka, T., (2006) Growth inhibitory factor (GIF) can protect from brain damage due to stab wounds in rat brain. Neurosci. Lett. 395, 220-223. (Pubitemid 43213148)
40. Ma, F., Wang, H., Chen, B., Wang, F., and, Xu, H., (2011) Metallothionein 3 attenuated the apoptosis of neurons in the CA1 region of the hippocampus in the senescence-accelerated mouse/PRONE8 (SAMP8). Arq. Neuropsiquiatr. 69, 105-111.
41. Chung, R. S., Vickers, J. C., Chuah, M. I., Eckhardt, B. L., and, West, A. K., (2002) Metallothionein-III inhibits initial neurite formation in developing neurons as well as postinjury, regenerative neurite sprouting. Exp. Neurol. 178, 1-12. (Pubitemid 35425604)
42. Montoliu, C., Monfort, P., Carrasco, J., Palacios, O., Capdevila, M., etal. (2000) Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons. J. Neurochem. 75, 266-273. (Pubitemid 30418192)
43. You, H. J., Oh, D. H., Choi, C. Y., Lee, D. G., Hahm, K. S., et al. (2002) Protective effect of metallothionein-III on DNA damage in response to reactive oxygen species. Biochim. Biophys. Acta 1573, 33-38. (Pubitemid 35279786)
44. Uchida, Y., Gomi, F., Masumizu, T., and, Miura, Y., (2002) Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J. Biol. Chem. 277, 32353-32359. (Pubitemid 34969053)
45. Liu, Y., Ren, H., Wu, C., Bai, S., Zhang, X., et al. (2004) Attenuation of zinc-induced neuronal death by the interaction of growth inhibitory factor with Rab3A in rat hippocampal neurons. Neurosci. Lett. 358, 149-152. (Pubitemid 38368191)
46. Irie, Y., and, Keung, W. M., (2003) Anti-amyloid beta activity of metallothionein-III is different from its neuronal growth inhibitory activity: structure-activity studies. Brain Res. 960, 228-234. (Pubitemid 36044580)
47. Erickson, J. C., Sewell, A. K., Jensen, L. T., Winge, D. R., and, Palmiter, R. D., (1994) Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 649, 297-304. (Pubitemid 24197224)
48. Masters, B. A., Kelly, E. J., Quaife, C. J., Brinster, R. L., and, Palmiter, R. D., (1994) Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA 91, 584-588. (Pubitemid 24041446)
49. Penkowa, M., and, Moos, T., (1995) Disruption of the blood-brain interface in neonatal rat neocortex induces a transient expression of metallothionein in reactive astrocytes. Glia 13, 217-227.
50. Penkowa, M., Caceres, M., Borup, R., Nielsen, F. C., Poulsen, C. B., et al. (2006) Novel roles for metallothionein-I + II (MT-I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I + II knockout mice. J. Neurosci. Res. 84, 1452-1474. (Pubitemid 44683139)
51. Chung, R. S., Penkowa, M., Dittmann, J., King, C. E., Bartlett, C., et al. (2008) Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J. Biol. Chem. 283, 15349-15358.
52. Asmussen, J. W., Von Sperling, M. L., and, Penkowa, M., (2009) Intraneuronal signaling pathways of metallothionein. J. Neurosci. Res. 87, 2926-2936.
53. Leung, Y. K., Pankhurst, M., Dunlop, S. A., Ray, S., Dittmann, J., et al. (2010) Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways. Exp. Neurol. 221, 98-106.
54. Sonn, K., Pankratova, S., Korshunova, I., Zharkovsky, A., Bock, E., et al. (2010) A metallothionein mimetic peptide protects neurons against kainic acid-induced excitotoxicity. J. Neurosci. Res. 88, 1074-1082.
55. Fitzgerald, M., Nairn, P., Bartlett, C. A., Chung, R. S., West, A. K., et al. (2007) Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp. Brain Res. 183, 171-180. (Pubitemid 47497715)
56. Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., et al. (2009) Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann. NY Acad. Sci. 1171, 59-76.
57. Borsello, T., and, Forloni, G., (2007) JNK signalling: a possible target to prevent neurodegeneration. Curr. Pharm. Des. 13, 1875-1886. (Pubitemid 47010160)
58. Wang, H., Brown, J., and, Martin, M., (2011) Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 53, 130-140.
59. May, P., Woldt, E., Matz, R. L., and, Boucher, P., (2007) The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann. Med. 39, 219-228. (Pubitemid 46676481)
60. Uchida, Y., Takio, K., Titani, K., Ihara, Y., and, Tomonaga, M., (1991) The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7, 337-347.
61. Higashi, Y., Asanuma, M., Miyazaki, I., and, Ogawa, N., (2004) Expression of metallothionein-III and cell death in differentiated catecholaminergic neuronal cells. Neurol. Res. 26, 671-676.
62. Koumura, A., Kakefuda, K., Honda, A., Ito, Y., Tsuruma, K., et al. (2009) Metallothionein-3 deficient mice exhibit abnormalities of psychological behaviors. Neurosci. Lett. 467, 11-14.
63. Miyazaki, I., Asanuma, M., Higashi, Y., Sogawa, C. A., Tanaka, K., et al. (2002) Age-related changes in expression of metallothionein-III in rat brain. Neurosci. Res. 43, 323-333. (Pubitemid 34828233)
64. Uchida, Y., and, Ihara, Y., (1995) The N-terminal portion of growth inhibitory factor is sufficient for biological activity. J. Biol. Chem. 270, 3365-3369.
65. Adlard, P. A., West, A. K., and, Vickers, J. C., (1998) Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease. Neurobiol. Dis. 5, 349-356. (Pubitemid 29037286)
66. Carrasco, J., Adlard, P., Cotman, C., Quintana, A., Penkowa, M., et al. (2006) Metallothionein-I and -III expression in animal models of Alzheimer disease. Neuroscience 143, 911-922. (Pubitemid 44834444)
67. Chung, R. S., Howells, C., Eaton, E. D., Shabala, L., Zovo, K., et al. (2010) The native copper- and zinc-binding protein metallothionein blocks copper-mediated Abeta aggregation and toxicity in rat cortical neurons. PloS One 5, e12030.
68. Meloni, G., Sonois, V., Delaine, T., Guilloreau, L., Gillet, A., et al. (2008) Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity. Nat. Chem. Biol. 4, 366-372. (Pubitemid 351693994)
69. Manso, Y., Adlard, P. A., Carrasco, J., Vasak, M., and, Hidalgo, J., Metallothionein and brain inflammation. J. Biol. Inorg. Chem. 16, 1103-1113.
70. Duce, J. A., Tsatsanis, A., Cater, M. A., James, S. A., Robb, E., et al. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867.
71. Costa, R., Ferreira-da-Silva, F., Saraiva, M. J., and, Cardoso, I., (2008) Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PloS One 3, e2899.
72. Yu, W. H., Lukiw, W. J., Bergeron, C., Niznik, H. B., and, Fraser, P. E., (2001) Metallothionein III is reduced in Alzheimer's disease. Brain Res. 894, 37-45. (Pubitemid 32197596)
73. Martin, B. L., Tokheim, A. M., McCarthy, P. T., Doms, B. S., Davis, A. A., et al. (2006) Metallothionein-3 and neuronal nitric oxide synthase levels in brains from the Tg2576 mouse model of Alzheimer's disease. Mol. Cell Biochem. 283, 129-137.
74. Irie, Y., and, Keung, W. M., (2001) Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid beta peptides. Biochem. Biophys. Res. Commun. 282, 416-420. (Pubitemid 32917885)
75. Adamo, A. M., Zago, M. P., Mackenzie, G. G., Aimo, L., Keen, C. L., et al. The role of zinc in the modulation of neuronal proliferation and apoptosis. Neurotox. Res. 17, 1-14.
76. Inoue, K., Takano, H., Shimada, A., and, Satoh, M., (2009) Metallothionein as an anti-inflammatory mediator. Mediators Inflamm. 2009, 101659.
77. Vasto, S., Candore, G., Listi, F., Balistreri, C. R., Colonna-Romano, G., et al. (2008) Inflammation, genes and zinc in Alzheimer's disease. Brain Res. Rev. 58, 96-105.
78. May, P., Herz, J., and, Bock, H. H., (2005) Molecular mechanisms of lipoprotein receptor signalling. Cell Mol. Life Sci. 62, 2325-2338. (Pubitemid 41500548)